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ABSTRACT 
 
Protein coding regions of the PrPC gene in 51 pigs belonging to 3 breeds namely 
Hampshire, Yorkshire, Blue Butt Cross (blue spotted cross from a Hampshire X 
Yorkshire), and a wild pig were studied. These breeds are used nationwide for 
commercial purposes. The PrPC gene of the pigs that code for prion proteins were 
sequenced and studied. Deletions of the octapeptide (WGQPHGGG) were observed in 13 
samples that belongs to the crossbreed Dark Cross sow 71 by Blue Butt Boar (Gummy 
bear). This hydrophobic repeat has been used in experiments as a model to investigate 
neurodegeneration in prion diseases. Also, it was used as vaccine where the octapeptide 
sequence was administered in a liposomal bilayer and when administered to an animal, 
the vaccine elicited a local or systemic, immunogen-specific immune response against 
amyloid proteins, peptides or fragments. In previous studies, prion proteins commonly 
have five or six repeats, while in this study, four octarepeats were obtained in all samples 
except the few that contained only three octarepeats. The presence of the octapeptide is 
said to be correlated with increased susceptibility of prion disease. If this is the case, 
these individuals may be less susceptible to prion disease as compared to other breeds. 
Still, research needs to be done to confirm this. Those sequences were then compared 
with the PrPC genes of other mammals. Based on these sequences, a phylogenetic tree 
was constructed. Also, the gender of the pigs does not seem to play role in whether the 
octapeptide deletion occurs. 
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PREFACE 
This thesis follows the style of American Society for Microbiology. 
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INTRODUCTION 
 
Prion diseases 
Prion diseases are neurodegenerative disorders caused by the pathogenic isoform 
of a normal constituent of cell membrane called prion protein (Johnson 2005). These 
diseases are collectively called transmissible spongiform encephalopathies (TSEs) and are 
named differently depending on the species they infect, and includes Kuru and 
Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in 
cows, scrapie in sheep, and chronic wasting disease (CWD) in deer and elk (Choi et al. 
2012). 
Prion disease leads to impairment of brain function, decline in intellectual 
function, and abnormal movements (National Institutes of Health 2014). About 10 -15% 
of the cases of human prion diseases are the result of mutations in the PrPC gene, while 
the remaining 85-90% are classified as either sporadic or acquired. 
Sporadic prion disease does not have a genetic predisposition or an identified 
mutation in the PrPC gene and occurs when the normal prion protein (PrPC) is transformed 
to an abnormal sporadic form of prion protein (PrPSC) (Figure 1). The mechanism for this 
transformation is yet unknown, but prion diseases are transmitted by consumption of 
infected feed or by contact with infected animals (Johnson 2005). The sporadic form of 
human prion disease includes sporadic CJD (sCJD), sporadic fatal insomnia (sFI), and 
variably protease-sensitive prionopathy (VPSPr). On the other hand, acquired prion 
disease is caused by the exposure to PrPSC from an external source, as in vCJD, BSE, and 
Kuru. In some cases, prion disease is caused through accidental exposure to PrPSC during 
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a medical procedure. This method of transmission is classified as iatrogenic (National 
Institutes of Health 2014). 
 
History of prion research 
The historical background of prion disease dates back to 1700, when a disease 
‘scrapie’ was first reported in sheep (Hunter 1993) but it did not receive public attention 
until the 1980s. Scrapie once was thought to be caused by sexual overactivity. It was then 
considered to be a viral disease. Broad scale research and production of several 
hypotheses occurred rapidly after reports that the scrapie from sheep was transmitted to 
mice (Morris and Gajdusek 1963) and from goats to mice (Chandler 1961, Chandler 
1963). Hunter (1993) showed that scrapie passed through an ultrafilter of 30 nm and was 
highly hydrophobic. He concluded its replication did not depend on intrinsic nucleic acid. 
 Kuru, a type of TSE, was first identified in humans as a strange encephalitis-like disease 
in the Fore tribe of Papua New Guinea. A young virologist, D. Carlton Gajdusek and his 
team were working to isolate a virus but all attempts were in vain (Gajdusek and Gibbs 
1964). They concluded cannibalism, a culture followed in Papua New Guinea, to be the 
vehicle of kuru transmission, but the causative organism or substance was still unknown 
(Liberski et al. 2012). Later, William Hadlow recognized a micrograph of kuru pathology 
to be reminiscent of scrapie, and kuru was finally identified as a type of TSE (Farquhar 
and Gajdusek 1981). Other TSE related diseases have their own history of identification 
and prevalence. 
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Stanley B. Prusiner (1982), forwarded the idea that prion disease is caused by 
protein and nothing else. Unlike other diseases, including viral diseases, prion disease 
does not follow the basic principles of the central dogma of molecular biology, which 
holds that diseases that are transmissible contain genetic material like DNA or RNA. 
Hence, he gave the term ‘prion’ to the protein, which was to be pronounced as ‘pree-on’ 
and derived from two words ‘protenacious’ and ‘infection’ (Prusiner 1982). Prion protein 
then changes its structure to an abnormal form, causing disease.  He, along with other 
researchers, then concluded that abnormal prion protein converts normal prion protein to 
abnormal form and this process occurs rapidly (Prusiner 1995) 
BSE was first discovered in Great Britain in 1986. The neuropathology of BSE 
was similar to that of scrapie in sheep, and so, the disease was recognized as a spongiform 
encephalopathy. Afterwards several cases of BSE were reported that resulted in epidemics 
among cows. Epidemiological studies revealed that meat-and-bone-meal (MBM) might be 
used as a vehicle to transfer the disease. Hence in June 1988, the U.K. government banned 
the use of ruminant-derived MBM to be fed to ruminants, but it was still allowed to be 
feed to pigs and poultry, as these animals were not thought to be susceptible to BSE. 
Several other cases occurred even after the ban, which gave rise to a new hypothesis that 
pigs and poultry might act as carriers and cross-contaminate the infected feeds. After the 
first case of vCJD was reported in 1996, feeding mammalian protein to any cattle was 
banned. After this ban in 1996, the BSE cases declined from 44,000 in 1992 to 57 after 
1996 (Smith and Bradley 2003). vCJD, which was thought to be acquired in people by 
consuming BSE contaminated beef, had some similarities with the previously known 
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human prion disease CJD (Ingram 2013).  Also, during the same decade when BSE 
outbreak in cattle and the vCJD outbreak in people, Feline Spongiform Encephalopathy 
(FSE) was confirmed in domestic cats in Great Britain as the result of eating pet food 
made with BSE. By the end of 1999, the number of cases of FSE recorded reached 87 
(World Health Organization, 1999).  
 
Prion protein overall structure: 
The widespread distribution of prion protein among mammals prompted 
biologists to determine its structure. Three-dimensional structure and functional 
properties of the proteins were then compared with nucleotide and amino acid sequences 
(Calzolai et al. 2005). Due to the low yield of the purified prion protein in previous work, 
it was difficult obtain structural results using NMR spectroscopy or X-ray 
crystallography. So, recombinant PrPC was developed to study the protein structure, 
which suggested that recombinant PrPSC contains three alpha helices and one small anti-
parallel beta sheet (Acevedo-Morantes and Wille 2014).  
 Based on NMR measurements, conformation of recombinant human PrPC was 
determined (Hosszu et al. 1999) as shown in Figure 2. It consists of a signal peptide, and 
with the addition of glycophosphatidylinisitol (GPI) anchor functions as a membrane 
attachment signal. PrPC is further made up of a flexible N- terminal domain and a largely 
helical C- terminal domain. The N-terminal domain is involved in the regulation of 
copper and zinc whereas the C-terminal domain is involved in the conversion of alpha 
helix to beta sheets during the development of prion disease. Both of these domains are 
independent of one another and do not interact (Stockel et al. 1998). The C-terminus 
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forms a globular domain, comprising three alpha helices and a short double stranded beta 
sheet, stabilized by a disulfide bond. The domain contains two N-linked glycosylation 
sites (Rheede et al. 2003). Similarly, conformations of PrPC of hamster (James et al. 
1997), bovine (Garcia et al. 2000), mouse (Riek et al. 1996, 1997), and others were also 
determined using NMR. Globular folds of all these mammals were highly similar 
(Rheede et al. 2003). This globular domain is highly conserved among various species, as 
the nucleotide sequences of different species encoding this globular domain are almost 
identical. (Dominikus et al. 2005). A study based on NMR structures has shown the pig 
prion protein has a single charge-effective amino acid substitution in the position 223 
relative to cow prion protein. In addition, amino acid replacement from Asn-173 in the 
cow prion protein to Ser-173 in pigs is found to stabilize the 100-173 loop in the protein 
due to its neutral charge. It is hypothesized that this extra stability may explain why 
naturally occurring prion diseases have not been reported in pigs. The study thus has 
presumed that this substitution might affect the protein structure (Prusiner 1998). Change 
in the conformation of normal PrPC to abnormal PrPSC is carried out by the increase in 
beta-sheet content from 3% to around 40%, whereas alpha-helix content is decreased 
from 40% to 30% (Cohen and Prusiner 1998). 
 
Prion protein octarepeat region 
Physiological function of prion protein explains how membrane-bound prion 
protein binds to copper in the N- terminal domain (Whittal et al. 2000). The octarepeat 
region in the N- terminal domain has been observed in residues 60-91 in PrPC of humans 
and other mammals, including pig, syrian hamster, and others. The prion protein in these 
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animals consists of four or more repeats of the residue sequence PHGGGWGQ. Those 
humans who contain extra octarepeats in their prion protein are prone to Creutzfeldt- 
Jakob disease (Goldfarb et al. 1991). Similarly, in an experiment done in mice, removal of 
the octarepeat domain helped in the slowing the progression of disease (Flechsig et al. 
2000). Also, when copper was added to wild prion protein, protease resistance was 
favored, which is a characteristic feature of the pathogenic form (Quaglio et al. 2001). The 
cellular membrane prion protein (PrPC) is GPI-anchored, which exists on the membrane 
surface (Vey et al. 1996), where exchange of divalent copper occurs (Pen᷈a et al. 1999, 
Waggoner et al. 2000). The above mentioned octarepeat peptide domain binds four Cu2+ 
ions with significant cooperativity as compared to other divalent metal ions (Whittal et al. 
2000). Circular dichroism (CD) studies have indicated that coordination in PHGGGWGQ 
and HGGG peptides develops from the imidazole ring of histidine amino acid and three 
amide nitrogen within HGGG unit (Bonomo et al. 2000). These studies suggested 
fundamental ideas on the functions of PrPC as a copper sensor as well as transporter, and 
also the role of octarepeat in transmembrane signaling leading to the copper-mediated 
conversion of PrPC to PrPSC (Burns et al. 2002). 
The octapeptide repeat (OR) region is a highly conserved part of PrPC in 
mammals (Harris et al. 1991). The 92-111 region is denoted as a non-OR region which is 
adjacent to the hydrophobic residues (112-127), and contains two additional His residues 
and which are also hypothesized to play a part in the prion conversion. A high degree of 
conservation is observed in the residues 90 to 127 among different mammals. Because the 
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OR region does not seem to be play a role in the conversion of prion to the abnormal 
form, the non-OR copper binding site is being studied currently.  
The non- OR copper binding site is found to be adjacent to the palindromic amino 
acid motif sequence AGAAAAGA. This palindromic motif is involved in causing the 
structural changes during the initial prion converting phase. A recent study has also shown 
that the interaction among copper and peptide, including both palindromic motif and non- 
OR residues induce beta-sheet formation, which results in the aggregation of the peptide 
segment (Giachin et al. 2015).  
 
Species barriers 
Though PrPC sequence is highly conserved among mammals, prions are not 
observed to transfer easily from one species to another (Collinge 2012). Slight 
polymorphisms in the amino acids might play a major role in the transmission efficiency 
(Beringue et al. 2008). For example, in the case of sheep, homozygosity for the 
V136R154Q171 (VRQ) allele has shown high susceptibility to classical scrapie whereas 
homozygosity in allele A136R154Q171 (ARQ) exhibits major resistance (Belt et al. 1995, 
Goldmann et al. 2016). In the same way, human susceptibility to TSE is influenced by the 
amino acid polymorphism at residue 129 (Collinge 2001, Wadsworth and Collinge 2007). 
Transmission of the TSE agent within the species was noted first in sheep scrapie in the 
1930’s (Belt et al. 1995). Cross species transmission of prion is less common than 
intraspecies transmission. The emergence of new vCJD strain in humans, after the BSE 
outbreak, has demonstrated the ability of prion disease to be transferred from one species 
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to the other. Conformational flexibility of the prion protein, along with the ability to 
infect foreign hosts, seems to play an important role in strain variation, but this is a 
complex process, which is difficult to comprehend (Beringue et al. 2008). 
Previous studies explained that the difference in the primary structure of protein 
between host and donor species is the major point where the species barrier resides. In an 
experiment by Scott et al. (1989), hamster PrPC was expressed in transgenic mice, which 
developed susceptibility to hamster scrapie (Kimberlin and Walker 1978) which resulted 
in the apparent lack of species barrier. Here, the PrPC gene of host and infecting species 
were identical. In this way, mice transgenic lines were developed for sheep (Crozet et al. 
2001, Vilotte et al. 2001, and Westaway et al. 1994), bovine (Beringue et al. 2006, 
Buschmann and Groschup 2005), human (Asante et al. 2002), and other mammals. Also, 
transgenic lines have been made by using gene replacement method. In this work, a series 
of inbred lines of transgenic mice were produced and PrPC genes were expressed in each, 
which allowed the study of the direct influence of the host PrPC gene in TSEs. Hence, 
these experiments gave the conclusion that identity in the PrPC sequence among 
transgenic host and donor leads to the increased susceptibility to TSE when compared to 
the wild type mice (Cancellotti et al. 2007). 
            Hence, interspecies transmission of prions results in varying outcomes based on 
the type of species. For example, some species can show resistance to infection, while 
some might possess asymptomatic disease which might act like a carrier and can pass 
disease to a different species more easily. Also, certain species can show permanent or 
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reversible change of strain properties, and some might show faithful propagation 
(Beringue et al. 2008). 
Past studies with the recombinant prion protein PrPC have explained  prion 
assembly as a nucleation-dependent polymerization process, which also gives different 
insight into the species barrier concept. In these studies, fibrils were made of bacterially- 
expressed PrPC in such a way that those were able to polymerize into amyloid fibrils 
either spontaneously or by adding preformed fibrils(Surewicz et al. 2006, Noinville et al. 
2008). In the study done by Surewicz et al. (2006), recombinant PrPC fibrils were 
generated using mouse, human or hamster PrPC. They were morphologically different to 
one another. Also, experiments were carried out to examine the cross-seeding capacities 
of the fibrils which concluded that mouse monomers could be converted by hamster fibril 
seeds, whereas the opposite could not happen. Once formed, the mouse fibril generated 
from the hamster can then polymerize the hamster PrPC monomers into fibrils. These 
newly formed hamster PrPC fibrils adopted different secondary structure as compared to 
that of mouse fibrils generated by mouse PrPC monomers. This study has also explained 
that point mutations can influence the seeding barrier by changing the conformation of 
amyloid fibrils with mutant fibrils and adopting PrPC of a different species. For example, 
in case of human variant PrPC, mutation at position 138 and 139 where isoleucine is 
replaced by methionine, the seeding capacity is affected, which is similar to that seen in 
the hamster protein. It resulted in the hamster- like fibril conformation (Jones and 
Surewicz 2005, Vanik et al. 2004). 
 
Risk of prion zoonoses 
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Transmission of prion disease from cattle to human is a major concern to public 
health. There is evidence of clinical disease in the transgenic mouse expressing human 
PrPC protein which were exposed to BSE prions (Beringue et al. 2012), whereas prion 
infection in spleen was observed in high proportion and infection in brain was seen in 
less than 10% of mice kept for longer incubation periods. Prions might not be harmful by 
the subclinical infection caused from foreign prions, but when they adapt to new host 
species, high lethality was obtained in the individuals of that species (Hill et al. 2000). 
This is important in terms of public health because humans colonized with silent vCJD 
prions can transfer prions to healthy individuals via blood transfusion, tissue donation, 
and other contamination during surgery (Weissmann 2002). In 1996, vCJD was found in 
a human caused by exposure to BSE strain (Collinge 2001). But the rate of vCJD 
transmission was very low which might be the result of the species barrier. Research has 
shown that during BSE outbreak, rate of vCJD was 1 in 4000 of UK population. 
(Spongiform Encephalopathy Advisory Committee position statement, 2008). 
 
Prions in pigs 
Naturally occurring prion diseases have not yet been identified in pigs (Sus 
scrofa). As pigs were clearly exposed to the ruminant derived meal during the British BSE 
epidemic, studies were conducted to examine if BSE was transmitted to them. But BSE 
was not found to be transmitted from feeding infected brain materials to pigs, while BSE 
was observed in animals when brain homogenate from BSE infected cows was inoculated 
to healthy pigs through intracerebral, intravenous, and intraperitoneal routes (Gibbs et al. 
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1979). Study of prion proteins in pigs is important because they are widely used in human 
daily life. More than one billion pigs are consumed by humans every year. Although 
natural TSEs have not yet been identified in pigs, there is a possibility these prion-disease-
resistant pigs can be carriers of replicating prions (Hammarstrom and Nystrom 2015). 
Since pigs are also considered to be excellent organ donors for humans, because humans 
and pigs share similar physiology, there is another possibility that prion disease could be 
transmitted to humans during xenotransplantation (Meng et al. 2005). 
 
Purpose of my research 
Based on species barrier, transmission of PrPSC, and to develop therapeutic 
interventions, the basic goal of all prion related research is to have knowledge and 
understanding of the structure and function of prion protein regions that are involved in 
the generation and aggregation of PrPSC. In this research, my objective was to sequence 
the prion encoding gene extracted from pig tissues (Figure 3) and look for polymorphisms 
in the sequences. The aim of this study was to see if the polymorphisms in the sequences 
have contributed to changes in copper binding domain of the prion protein along with 
studying if these have links to species diversity. Subsequently, the sequences were 
compared with other prion disease susceptible and non-susceptible mammals. Because 
pigs live in close proximity to humans and though there are no naturally reported pig prion 
disease, research on pig prion protein should be given prior importance and should be 
continued. 
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MATERIALS AND METHODS 
 
Sample collection: 
A total of 51 samples were sampled, 50 from domestic piglets collected from Fort 
Hays State University farm belonging to 3 breeds, namely Hampshire, Yorkshire, Blue 
Butt Cross (blue spotted cross from a Hampshire X Yorkshire), and 1 from a wild pig. 
Table 1 shows a list of 50 samples taken from the FHSU farm. These breeds are used 
nationwide for commercial purposes. Out of 50 domestic pigs, 23 were female and 27 
were male. The pigs’ tails had been docked and placed in 70% ethanol and stored in -
20°C freezer until DNA extraction. 
 
Genomic DNA isolation: 
Total genomic DNA was isolated from each sample using the extraction kit from 
Qiagen (Hilden, Germany) as per the instruction from manufacturer and eluted in 50 µl of 
nuclease-free water. Before starting extracting procedure, samples were washed with 
double-distilled water. The extracted DNA was visualized in 1% agarose gel to verify the 
DNA was non-degraded. Furthermore, the quality and quantity of DNA was measured 
using a spectrophotometer (Nanodrop Technologies, Wilmington, DE). 
 
Polymerase Chain Reaction:  
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Polymerase Chain Reaction (PCR) was used to detect the presence of PrPC genes 
in samples of isolated genomic DNA. Primer sequences from Martin et al. (1995), 
obtained from Sigma, were used in PCR reactions. 
The forward primer was Por PrP fwd 5’CATTTGATGCTGACACCCTCTTTA3’ and 
reverse primer was Por Prp rev 5’ATGAGACACCACCACTACAGGGCT3’. DNA was 
amplified using Phusion Polymerase kit obtained from Biolabs Inc. (Ipswich, MA). 
Annealing temperature was identified as 60 oC which did not match with the one used by 
Martin et al. (1995). 
Amplification of selected regions was carried out in 50 µL of reaction mixture. 
PCR components were combined in 0.5 mL micro centrifuge tube as follows: 10 µL of 
5X Phusion High Fidelity Buffer, 2.5 µL of 10 µM PrP forward primer, 2.5 µL of 10 µM 
reverse primer, 1 µL of 10 mM dNTPs, 0.5 µL Phusion polymerase, 2 µL of template 
DNA, and 31.5 µL of nuclease-free water. The optimized PCR conditions were 98 oC for 
30 seconds, followed by 30 cycles of 98 oC for 10 seconds, 60 oC for 30 seconds, and 72 
oC for 30 seconds. The final elongation was occurred at72 oC for 10 minutes. 
 
Agarose gel electrophoresis, PCR purification, and sequencing 
The qualitative assessment and quantitative estimation of amplicons generated by 
PCR was verified by gel electrophoresis using Tris-acetate-EDTA in 1% agarose gels 
(Agarose low EEO, Thermo Fisher Scientific, Waltham, MA) and stained with Sybersafe 
obtained from Invitrogen (Carlsbad, CA). The one Kb DNA ladder, obtained from 
Promega, (Madison, WI), was used in the gel and the loading dye used was from 
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GelPilot. Correct amplicons were purified using QIAquick PCR purification kit (Qiagen, 
Hilden, Germany) following manufacturer’s instructions and eluted in nuclease-free 
water. Each sample having a concentration of around 30 ng/L was then sequenced at the 
Sequencing and Genotyping Facility of Kansas State University (Manhattan, KS) using a 
3730 DNA Analyzer (Applied Biosystems, Foster City, CA) and Genewiz (South 
Plainfield, NJ).  
 
Sequence alignment and data analysis: 
From the nucleotide sequences, protein accession, nucleotide accession, gene 
annotation, and full length protein sequences were obtained using National Center for 
Biotechnological Information (NCBI). Based on the sequence of pig prion protein 
obtained from NCBI, sequences of all 51pig prion proteins were compared and 
polymorphisms were identified. Nucleotide sequences were aligned in Clustal Omega 
(Version 1.2.1, Thompson et al. 1994) and BioEdit Sequence Alignment Editor (Version 
7.2.5, Hall 1999). 
 
Phylogenetic tree construction 
Prion sequences of other mammals were retrieved from NCBI GenBank; 
Cricetulus griseus (Chinese hamster), Canis familiaris (dog), Bos taurus (cow), Felis 
catus (cat), Ovis aries (sheep), Homo sapiens (humans), and Cervus Nippon (sika deer) 
and analyzed with the sequences obtained from pig samples. A phylogenetic tree based 
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on Maximum Likelihood method was constructed using mega software (Version 7. 0. 18, 
Kumar et al. 2016). 
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RESULTS 
 
PrPC Gene Detection by PCR 
The PCR assay demonstrated the presence of the PrPC gene in all 51 samples, 
including domestic and wild pigs (Figure 4). Based on the sequences obtained from the 
DNA Sequencing and Genotyping Facility at Kansas State University and Genewiz, the 
nucleotide sequences of length 774 base pairs were obtained and those sequences were 
translated into amino acid sequences of length 257. A few multiple peaks of nucleotides 
were obtained in samples 23-1, 23-4, 24-1, and 24-7.Sequence was not obtained for 
sample 23-5.  
Polymorphisms in the PrPC gene 
Four octapeptide repeats (PHGGGWGQ) were observed in all the samples based 
on the aligned translated protein sequences of PrPC gene. But in samples, 9-1, 9-2, 9-4, 9-
5, 9-6, 9-7, 9-8, 9-9, 9-11, 23-6, 23-7, 23-8, and 23-10, eight amino acids WGQPHGGG 
or one complete octapeptide repeat domain were deleted (Figure 5 and 6). These samples 
with missing amino acids belong to the same pig cross, namely ‘Dark Cross sow 71 by 
Blue Butt Boar (Gummy bear)’. The octapeptide repeat was conserved in all other 
samples from domestic pigs as well as the wild pig. The octapeptide repeat region was 
followed by 21 non-octapeptide repeats, after which an alanine rich palindromic amino 
acid motif sequence AGAAAAGA was observed in all the samples, including other 
mammals. Hydrophobic amino acids were found in a row, starting immediately following 
17 
	
the palindromic sequence AGAAAGA. Polymorphism was not observed to be related 
with the gender of the pigs. Both male and female pigs had presence and absence of the 
octapeptide deletion. 
Phylogenetic tree 
A molecular phylogenetic tree was obtained using Maximum Likelihood method 
with Mega 7 software. All gaps and missing data were eliminated and an unrooted 
analysis was performed. The branch length signifies the rate of nucleotide substitutions. 
In the tree obtained, branch lengths of most of the pig samples were equal due to almost 
identical sequences. Branch lengths of rest of the pig samples and other mammals are 
shown in Figure 7. Rest of the mammals appeared in a different clade. 
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DISCUSSION 
 
The deletion of one octapeptide as observed in the crossbreed samples 9-1, 9-2, 9-
4, 9-5, 9-6, 9-7, 9-8, 9-9, 9-11, 23-6, 23-7, 23-8, and 23-10 can be the result of mutated 
PrPC. Such mutation might result in the mutation of the PrPC protein (Acevedo-Morantes 
and Wille 2014). Experiments conducted previously have shown that the octapeptide 
repeat mutation might result in genetic prion disease in humans. Insertion of additional 
octapeptide repeats makes an individual more prone towards the prion disease and thus 
the degree of prion aggregation was found to be proportional to the number of 
octapeptide repeats present. The increased octapeptide repeats resulting in increased 
aggregation can be the result of inheritance of mutated octapeptide repeat sequence (Yu 
2007). The wild pig sample used in this study did not show any deletion of octapeptides, 
which might suggest that wild pigs have the same prion susceptibility to prion disease as 
that of domestic pigs. 
The octapeptide repeat motif  PHGGGWGQ (Figure 5 and 6), observed in the N-
terminal domain of the PrPC protein has a high affinity for copper ions (Cu2+) and other 
divalent cations such as zinc in specific pH conditions. Copper binding plays an 
important role in converting alpha helix to a beta sheet structure. The above mentioned 
13 samples with one octapeptide deletion in each, contain only three octapeptide repeats 
which might have reduced the copper binding domain from two to one, since two 
octapeptide repeats bind to one Cu2+ ion (Stockel et al. 1998). This might contribute to 
fewer possibility of converting an alpha helix to a beta sheet. This can be one of the 
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reasons behind why the crossbreeds Dark Cross sow 71 by Blue Butt Boar (Gummy 
Bear) might be less susceptible to prion disease than the rest of the pig breeds. Research 
has shown that one Cu2+ ion binds to two octapeptides and the imidazole side chain of the 
histidine present in the octapeptides acts as a chelating ligand. NMR spectroscopy has 
demonstrated that in the absence of copper ions, octapeptide repeats fail to achieve 
secondary or tertiary structure.  (Stockel et al. 1998). Recent research has suggested that 
zinc binds to octapeptide and the C-terminal domain via electrostatic interaction which 
contributes in the tertiary structure contact. This contact then further results to the 
familial prion disease (Spevacek 2013). In the mice without prion protein, or with 
infectious prion protein, copper and iron metabolism is abnormal (Brown 2003). 
AGAAAAGA, is the hydrophobic core of the protein and is the N-terminal 
palindrome of PrPC. It was present in all 51 samples sequenced and is shown in Figure 5 
and 6. This is a highly conserved sequence motif found in most of the mammals studied 
so far (Acevedo-Morantes and Wille 2014). Norstrom and Mastrianni (2005) suggested 
that this AGAAAAGA palindrome is required for obtaining the PrPSC conformation. 
Mutants without the palindromic sequence were unable to convert PrPC to PrPSC. Also, 
the palindromic motif was found to facilitate the association of PrPC with PrPSC,which 
results in the aggregation of abnormal protein (Norstrom and Mastrianni 2005). 
The deleted sequences WGQPHGGG as seen in pigs of crossbreed Dark Cross 
sow 71 by Blue Butt Boar (Gummy bear) was noted to be used as vaccine against prion 
disease. In the past, Nicolau and Kapetanovic (2004) had worked on the vaccine against 
prion diseases. They used different segments of prion protein as a vaccine, including the 
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deleted sequences WGQPHGGG, where it is administered in a liposomal bilayer. When 
administered to an animal, the vaccine elicits a local or systemic, immunogen-specific 
immune response against amyloid proteins, peptides or fragments, and prevents, stops or 
hinders amyloid deposition caused by prions. Traditional vaccines, made from either 
purified antigens or the attenuated form of pathogen, which illicit the immune responses 
in the individual did not work for prion disease. This might be because it is molecular 
structure of the abnormal prion protein not the nucleic acid sequences, that is involved in 
causing prion disease (Nicolau and Kapetanovic 2004). 
The phylogenetic tree (Figure 7) shows the evolutionary history of the prion 
proteins. Branch lengths of most of the pig samples was equal due to almost identical 
sequences and the remaining samples, which were seen in a different clade, are those 
having octapeptide deletion . The sequences of mammals subjected for phylogeny 
analyses were chosen in such a way that both prion susceptible mammals like cow, sheep, 
cat, human, and prion non-susceptible mammals like dog and pig are included for study. 
Taking into consideration that both pigs and dogs do not easily get prion disease, their 
phylogeny was expected to be closely related, but result was not obtained as expected. 
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CONCLUSION 
 
In the samples 9-1, 9-2, 9-4, 9-5, 9-6, 9-7, 9-8, 9-9, 9-11, 23-6, 23-7, 23-8, and 
23-10, eight amino acids WGQPHGGG were deleted. All these samples with deletions 
are from the same breed (Dark cross sow 71 by Blue butt boar). From the observed 
results, and based on the research done by Stockel et al. (1998),  we can hypothesize that 
the Dark Cross sow 71 by Blue Butt Boar (Gummy Bear) crosses might be less 
susceptible to prion disease as these crosses have one less octapeptide repeat as compared 
to rest of the domestic breeds and wild pig. Because two octapeptide repeats bind to one 
Cu2+ ion, there will be one less octapeptide repeat in these breeds that can bind Cu2+ ion, 
which might contribute to lower possibility of conversion of alpha helix to beta sheets. 
The result might also indicate that wild pig’s prion susceptibility is similar to that of the 
domestic pigs having four octapeptide repeats and wild pigs might have been separated 
from the herd of domestic pigs in the course of time. This study might be valuable if this 
possibility is investigated in future animal studies. Differences in the susceptibility might 
be observed when the prion disease infected brain material is injected in the brain of 
these pigs. Those pigs with one less octapeptide repeat might show disease at a lower rate 
as compared to the others with four octapeptide repeats. Also, the gender of the pigs does 
not seem to play role in disease susceptibility. 
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Sample No. Individual Crosses 
9-1 to 9-11 Dark Cross sow 71 by Blue Butt Boar (Gummy bear) 
10-1 to 10-7 Pure York sow by Blue Butt Boar (Gummy bear) 
19-1 to 19-7 Pure Duroc sow by Berkshire Boar 
22-1 to 22-5 Pure York sow by Blue Butt Boar (Gummy bear) 
23-1 to 23-10 Dark Cross sow 71 by Blue Butt Boar (Gummy bear) 
24-1 to 24-10 Dark Cross (Half Hampshire by Half Duroc) bred by Blue Butt Boar 
(Gummy bear) 
 
Table 1. Overview of DNA samples used in the study of  polymorphism in the PrPc prion 
protein gene in pigs. 
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Figure 1. Normal and abnormal form of prion protein. Normal prion protein has amino 
acids in alpha helix with less than 5% of beta sheets. Abnormal prion protein is a 
misfolded protein, where majority of alpha helices are converted into beta sheets resulting 
in more than 50% of beta sheets. (Source: Mayo Foundation of Medical Education and 
Research). Accessed on: 3/16/2017 
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Figure 2. Organization of human PrPC. The PrPC, having 253 amino acid residues, 
contains one signal peptide (1-22), four octapeptide repeats (113-135), one hydrophobic 
region (113-135), two N-linked glycosylation sites (181 and 197 residues), and one 
glycophosphatidylinositol-anchor signal (232-254). Mutated prion protein contains up to 
nine additional octapeptide repeats or deletion of one octapeptide. The palindromic amino 
acid motif AGAAAAGA lies in the hydrophobic region. (Source: Acevedo-Morantes and 
Wille 2014) 
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 Figure 3. Piglets of approximately 10 days old at Fort Hays State University farm. 23 
female and 27 male pigs were studied.Tails of the piglets are docked a few days after 
their birth so they do not hurt each other. 
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Figure 4. Electrophoresis gel picture of amplified PCR fragment of PrPC gene obtained 
from the pigs at Fort Hays State University farm. Lane 1: 1 Kb ladder (Promega). Lane 2-
10: PCR amplicons of sample 9-1 to 9-9. 
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Figure 5: Deletion of octapeptide WGQPHGGG observed during multiple alignment of 
PrPC prion protein  in pig samples 9-1, 9-2, 9-4, 9-5, 9-6, 9-7, 9-8, 9-9, and 9-11. All 
these samples with deletions are from the same breed (Dark cross sow 71 by Blue butt 
boar) ‘Dashes‘ represent Deleted amino acid, ‘Asterisks’ represent gaps. A- Alanine, G- 
Glycine, V- Valine, K- Lysine, W- Tryptophan, Q- Glutamine, P- Proline, H- Histidine, 
S- Serine, T- Threonine, and N- Asparagine. 
9-1 
9-2 
9-4 
9-5 
9-6 
9-7 
9-8 
9-9 
9-11 
Palindromic amino acid motif (AGAAAAGA) Four octarepeats (PHGGGWGQ) 
41 
	
 
 
 
 
 
Figure 6: Deletion of octapeptide WGQPHGGG observed during multiple alignment of 
PrPC prion protein  in pig samples 23-6, 23-7, 23-8, and 23-10. All these samples with 
deletions are from the same breed (Dark cross sow 71 by Blue butt boar). 
‘Dashes‘represent deleted amino acid, ‘Asterisks’ represent gaps.  A- Alanine, G- 
Glycine, V- Valine, K- Lysine, W- Tryptophan, Q- Glutamine, P- Proline, H- Histidine, 
S- Serine, T- Threonine, and N- Asparagine. 
23-6 
23-7 
23-8 
23-10 
Palindromic amino acid motif (AGAAAAGA) Four octarepeats (PHGGGWGQ) 
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Figure 7. Phylogenetic tree derived from prion nucleotide sequences of pigs and few 
other mammals. 
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Appendix 1: Amino acid sequences 
1. Sus scrofa (GenBank)  
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLISFLLFPPFXS 
 
2. 9-1 
MVXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
3. 9-2 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRPKXGPV*SSXSSPPVILLXLFPPFXS 
 
4. 9-3 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
5. 9-4 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWRQGGGSRGR*SRPSNPKTNMKHVAGAAATGAVGGGLGGYMLGSAMSKP
LIHFGSDYEDRFYRENMYRYPNQMYYRPLDQFSNQNIFVHDCLNISVNHCTMTTTTKGENFTNTDVKNIDRVEXT
DVHHPVPTKVQGLLP-KXGPM*SSXSSAPVILFXLSPPVXS 
 
6. 9-5 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRWR*SGPSHPKTNMNHVPGATANGAVGGGLGGDMLGGAMSNP
LVRFVSDYQDRFYRENKYRYPHQIFYRPLDQFYYQPIFVHDCLNISVHHCTMTTTTKGENSTTTDGEIINHVEXTD
EHHPVPTKVQGLLP-KXGPRRSSXSWPPVILFXLSPPDXS 
 
7. 9-6 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRGR*SKPSNPKTNMKHVAGATATGAVGGGLGGYMLGSAMSNP
LIHFVSDYEDRFYRENMYRYPNQMYYRPLDQFNYQTIFVHDCLNISVHHCTVTTTTKGENFTNTDVKIIDRAEXT
DVHHPVPTKVRGVLP-KXRPMRSSXSSPPVILLXLSPPFXS 
 
8. 9-7 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
9. 9-8 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
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10. 9-9 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGC*RQGGGSRWRQSGASHPKTNMNHVPGTTANGAVGGGLGGYMLGGPMSNP
LVRFVSNYEDRFYRENKYRYPNQNFYRPPNQFNYQPIFVHDCLNISVHDCTMTTTTKGENSTNTDVKNINHTEXT
DDHHPVPTKVQGLLP-KXSPRRSSXSWATVILLXLSPRDXS 
 
11. 9-10 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
12. 9-11 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRGR*SGASHRKTNMKHVPGATATGAVGGGLGGDMLGGAMSNP
LVRFVSDYQDRFYRENKYRYPNQNFYRPLNQFNYQPIFVHDCLNIFVHHCTMTTTTKGENSTNTDGKNIDHAEXT
DDHHPVATKVQGLLPKXGPMRSSXSWAPVILFXLSPPDXS 
 
13. 10-1 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
14. 10-2 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
15. 10-3 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
16. 10-4 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
17. 10-5 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
18. 10-6 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
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19. 10-7 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
20. 19-1 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
21. 19-2 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRPKXGPV*SSXSSPPVILLXLFPPFXS 
 
22. 19-3 
MXXKSXXGGWILVLXCGRME*HRXSAXSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
23. 19-4 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
24. 19-5 
MXXKSXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
25. 19-6 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRPXKXGPV*SSXSSPPVILLXLFPPFXS 
 
26. 19-7 
MXXKSXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
27. 22-1 
MXXEXPIGGWVLVLXCGSME*HMXSSKSDQXLAEEGTLXXGAYTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRPXKXGPV*SSXSSPPVILLXLFPPFXS 
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28. 22-2 
MXXKXXXGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
29. 22-3 
MXXKIXIGGWILVLXCGRME*HRXSAKSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
30. 22-4 
MXXENPIGGWILVLXCGSME*HMVSSQNDQXLAGEGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRXXKXGPV*SSXSSPPVILLXLFPPFXS 
 
31. 22-5 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
32. 23-1 
V*XKLHILCWILVLGRFRNXQWXVASYKKXPSLAW**TLXXGAYPXGRVDMEXNPYPPQGGGGWGHPQGGGG
GQPHRGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVGTDVHHPVPERVRGVRP-KEGPV*SSXSSPPVILLXLFPSFSS 
 
33. 23-2 
MXXKIXIGGWILVLXCGSME*HRXSAKSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
34. 23-3 
XXXKTXXGGWILVLXCGRME*HRXSARSDXSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPEXVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
35. 23-4 
VLXNLQVLLXXAXLGRYRNXQWXVRSYERXQXLAGW*SLXXGAWTLGRVVMEXNPFPPKGGGGWGHPQGGG
GGQPHIGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGS
AMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMI
ERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
36. 23-6 
MXXESXIGGWILVLXCGRME*HRXSAKSDQXLAEEGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSR
PLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERVV
XTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
 
 
 
 
47 
	
37. 23-7 
MXXKSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGCWRQGGGSRWR*SGASHPKTNMKHVPGATATGAVGGGLGGYMLGGAMSNP
LVRFVSDYEDRFYREYKYRYSNQNFYRPLNQFYYQPIYVHDCLNIFVHHCTMTTTTKGENFTTTDGEIIDRAEXT
DEHHRVATKVQGVLP-KXGPMRSSXSSPPVILFXLSPRFXS 
 
38. 23-8 
MXKVSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQP
HGGGWGQPHGGGWGQPHGGGGWGQGGGSHGH*NKPSNPKTNMKHVAGAAATGAVGGGLGGYMLGSAMSK
PLIHFGSDYEDRFYRENMYRYPNQMYYRPLDQFSNQNIFVHDCVNISVKHCTVTTTTKGENFTNTDVKMIDRVV
XTDVHHPVPKRVQGVLP-KXSPM*SSXSSPPVILLILFPPFXS 
 
39. 23-9 
MXXKSXIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
40. 23-10 
MXXKVSHIGGWILVLXCGRME*HRXSARSDQSLAEDGTLXXGADTQGRVVLEXNRYPPQGGG~~~~~~~~GWGQ
PHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMS
RPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERV
VXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
41. 24-1 
V*XKLEILYWXMEASDLWGSXQ*HITSYKKMQGLAGCGTLXXGAYTLGRVVLGXNPFPPQGGGGWGQPQGGG
WGQPHRGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLG
SAMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVK
MIERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
42. 24-2 
XKXXQNPILGWVLVXXCGSXE*XXAS*KNEQXLAGEGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
43. 24-3 
VXXTLHIRGPWTVVGGYHNPQLXVVDXGRX*YL*RWCSAXXGPWXXDWVLAKTRKGXPPMLSLG*GRPQGGG
GARRXIPCRGRASYGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSFSSPPVILLXLFPPFPS 
 
44. 24-4 
MXRNPIFGWILXIXWGNXQ*XRXSAKKEQGLAGGGTLXXGAYTQGRVVLEXNRFPPQGGGGWGQPHGGGWGQ
PHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMS
RPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIERV
VXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
45. 24-5 
VXXTLPIRGWILVLGGFSNRXWXLVS*KKXQXLAW**SLXXGAYPXGWVVMEXNRYPPKGGGGWGHPQGGGW
GQPHRGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
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46. 24-6 
XTXRNPMFGMXSLXIXCGRXQ*HRXSAKNDQGLAGGGTLXXGAYTQGRVVLEXNRYPPQGGGGWGQPQGGG
WGQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLG
SAMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVK
MIERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
47. 24-7 
XPXXQILILGEXVLVLXFGNXE*XVVSYKNEQXLAGEGTLXXGAYTLGRVVMEXNRYPPQGGGGWGQPHGGG
WGQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLG
SAMSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVK
MIERVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
48. 24-8 
MXXKSXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
49. 24-9 
MXXKIXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGWG
QPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
 
50. 24-10 
MXXKXXIGGWILVLXCGRME*HRXSARSDQXLAEDGTLXXGADTQGRVVLEXNRYPPQGGGGWGQPHGGGW
GQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSA
MSRPLIHFGSDYEDRYYRENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDVKMIE
RVVXTDVHHPVPERVRGVRP-KXGPV*SSXSSPPVILLXLFPPFXS 
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Appendix 2. Pig prion protein information  
Nucleotide accession: L07623.1 
Protein accession: AAA92862.1 
Gene annotation: Sus scrofa prion protein (PrP) gene, complete cds 
Coding sequence: 1-774 base pairs 
Amino acid feature: Putative glycosylation sites, base pairs 185 and 201 
Protein translation: 
MVKSHIGGWILVLFVAAWSDIGLCKKRPKPGGGWNTGGSRYPGQGSPGGNRYP
PQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGGWGQGGGSHGQ
WNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGSDYEDRYY
RENMYRYPNQVYYRPVDQYSNQNSFVHDCVNITVKQHTVTTTTKGENFTETDV
KMIERVVEQMCITQYQKEYEAYAQRGASVILFSSPPVILLISFLLFLIVG 
 
 
